tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Affimed receives Nasdaq delisting notice
PremiumThe FlyAffimed receives Nasdaq delisting notice
3M ago
Affimed downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Affimed downgraded to Neutral from Buy at H.C. Wainwright
3M ago
Affimed’s Insolvency Proceedings and Liquidity Crisis Lead to Hold Rating
Premium
Ratings
Affimed’s Insolvency Proceedings and Liquidity Crisis Lead to Hold Rating
3M ago
Affimed Files for Insolvency Amid Financial Challenges
PremiumCompany AnnouncementsAffimed Files for Insolvency Amid Financial Challenges
3M ago
Affimed announces filing for opeing of insolvency proceedings
Premium
The Fly
Affimed announces filing for opeing of insolvency proceedings
3M ago
Affimed’s Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns
Premium
Ratings
Affimed’s Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns
3M ago
Affimed Therapeutics (AFMD) Q4 Earnings Cheat Sheet
PremiumPre-EarningsAffimed Therapeutics (AFMD) Q4 Earnings Cheat Sheet
4M ago
Affimed price target lowered to $11 from $15 at Wells Fargo
Premium
The Fly
Affimed price target lowered to $11 from $15 at Wells Fargo
8M ago
Affimed price target lowered to $7 from $10 at H.C. Wainwright
Premium
The Fly
Affimed price target lowered to $7 from $10 at H.C. Wainwright
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100